Quick Answer
Barinthus Biotherapeutics plc. reported Total Revenue of $0.00 for fiscal year 2025.
Barinthus Biotherapeutics plc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $14.97M | +1766.5% |
| 2023 | $802.0K | -98.2% |
| 2022 | $44.70M | +16580.2% |
| 2021 | $268.0K | -94.4% |
| 2020 | $4.82M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2024 | $14.97M | — | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | -100.0% | -100.0% |
| June 30, 2023 | $334.0K | -98.0% | -28.6% |
| March 31, 2023 | $468.0K | -96.9% | -92.4% |
| September 30, 2022 | $6.17M | +32347.4% | -63.9% |
- Barinthus Biotherapeutics plc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, Barinthus Biotherapeutics plc.’s total revenue has declined by 100.0% (from $4.82 million to $0.00).
- The most recent figure is from Barinthus Biotherapeutics plc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: